全文获取类型
收费全文 | 1509篇 |
免费 | 99篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 26篇 |
妇产科学 | 50篇 |
基础医学 | 271篇 |
口腔科学 | 17篇 |
临床医学 | 210篇 |
内科学 | 187篇 |
皮肤病学 | 9篇 |
神经病学 | 121篇 |
特种医学 | 76篇 |
外科学 | 198篇 |
综合类 | 14篇 |
预防医学 | 155篇 |
眼科学 | 16篇 |
药学 | 102篇 |
肿瘤学 | 147篇 |
出版年
2021年 | 14篇 |
2020年 | 16篇 |
2019年 | 20篇 |
2018年 | 29篇 |
2017年 | 27篇 |
2016年 | 18篇 |
2015年 | 28篇 |
2014年 | 21篇 |
2013年 | 34篇 |
2012年 | 50篇 |
2011年 | 66篇 |
2010年 | 43篇 |
2009年 | 36篇 |
2008年 | 69篇 |
2007年 | 50篇 |
2006年 | 64篇 |
2005年 | 46篇 |
2004年 | 50篇 |
2003年 | 42篇 |
2002年 | 55篇 |
2001年 | 36篇 |
2000年 | 36篇 |
1999年 | 38篇 |
1992年 | 18篇 |
1991年 | 25篇 |
1990年 | 35篇 |
1989年 | 28篇 |
1988年 | 18篇 |
1987年 | 37篇 |
1986年 | 24篇 |
1985年 | 24篇 |
1984年 | 28篇 |
1983年 | 33篇 |
1982年 | 16篇 |
1981年 | 18篇 |
1980年 | 13篇 |
1979年 | 41篇 |
1978年 | 26篇 |
1977年 | 26篇 |
1976年 | 19篇 |
1975年 | 24篇 |
1974年 | 27篇 |
1973年 | 20篇 |
1972年 | 33篇 |
1971年 | 19篇 |
1970年 | 18篇 |
1969年 | 14篇 |
1968年 | 16篇 |
1967年 | 21篇 |
1966年 | 11篇 |
排序方式: 共有1609条查询结果,搜索用时 531 毫秒
21.
22.
23.
24.
25.
26.
27.
Tien-Yuan?Wu Ying?Huang Chengyue?Zhang Zheng-Yuan?Su Sarandeep?Boyanapalli Tin?Oo?Khor Hu?Wang Hongxia?Lin Murugesan?Gounder Leonid?Kagan Ioannis?P.?Androulakis Ah-Ng?Tony?KongEmail author 《Journal of pharmacokinetics and pharmacodynamics》2015,42(4):401-408
3,3′-Diindolylmethane (DIM) has been investigated as a potential anti-cancer chemopreventive agent in many preclinical and clinical studies. In this study, we sought to characterize the pharmacokinetics of DIM and to build a pharmacokinetic (PK) and pharmacodynamic (PD) model of the DIM-induced gene expression of phase II drug metabolizing enzymes (DME), which potentially links DIM’s molecular effects to its in vivo chemopreventive efficacy. DIM (10 mg/kg) was administered intravenously (i.v.) to male Sprague–Dawley rats and blood samples were collected at selected time points for 48 h. The plasma concentration of DIM was determined using a validated HPLC method. The mRNA expression of NQO1, GSTP1 and UGT1A1 in blood lymphocytes was measured using quantitative PCR. An indirect response model was employed to relate the concentration of DIM to the expression of the genes NQO1, GSTP1 and UGT1A1, which were chosen as PD markers for DIM. After i.v. administration, the plasma concentration of DIM declined quickly, and the expression of target genes increased significantly, peaking at 1–2 h and then returning to basal levels after 24 h. The parameters in the PK–PD model were estimated. The PK–PD model aptly described the time delay and magnitude of gene expression induced by DIM. Our results indicate that DIM is effective at inducing various phase II DME, which are capable of detoxify carcinogens. This PK–PD modeling approach provides a framework for evaluating the acute effects of DIM or other similar drugs in clinical trials. 相似文献
28.
29.
30.
Ming Yu Mary T Guaraldi Mahesh Mistry Mikhail Kagan Jennifer L McDonald Kenneth Drew Heike Radeke Michael Azure Ajay Purohit David S Casebier Simon P Robinson 《Journal of nuclear cardiology》2007,14(6):789-798
BACKGROUND: BMS-747158-02 is a fluorine 18-labeled pyridaben derivative designed as a new myocardial perfusion imaging agent for use with positron emission tomography (PET). This study evaluated BMS-747158-02 in animal models of cardiac perfusion and compared it with established single photon emission computed tomography agents. METHODS AND RESULTS: In a rat biodistribution study, BMS-747158-02 (15 microCi) had substantially higher myocardial uptake than technetium 99m sestamibi (100 microCi) at 15 minutes (3.5% +/- 0.3% %ID/g vs 1.9% +/- 0.1% %ID/g) and 120 minutes (3.2% +/- 0.4% of injected dose per gram vs 1.8% +/- 0.0% of injected dose per gram) after intravenous administration. Uptake ratios of heart to lung and liver at 60 minutes were also higher for BMS-747158-02 (12.7 +/- 1.4 and 3.7 +/- 0.2, respectively) than Tc-99m sestamibi (5.9 +/- 0.5 and 2.4 +/- 0.4, respectively). In an isolated rabbit heart model at flow rates of 1.66 to 5.06 mL x min(-1).g(-1) wet left ventricular weight, the net BMS-747158-02 heart uptake increased proportionally (0.93 +/- 0.15 to 2.44 +/- 0.40 mL.min(-1) x g(-1)) and to a greater extent than that of thallium 201 (0.76 +/- 0.02 to 1.11 +/- 0.02 mL x min(-1) x g(-1)) or Tc-99m sestamibi (0.49 +/- 0.03 to 0.77 +/- 0.08 mL x min(-1) x g(-1)). PET imaging with BMS-747158-02 showed a clear and sustained cardiac uptake in rats, rabbits, and nonhuman primates with minimal lung interference and rapid liver clearance. Myocardial perfusion deficit zones created by either permanent left coronary ligation or reperfusion after ligation in rats were both clearly identified on PET cardiac images of BMS-747158-02 and had good agreement with in vitro histology. CONCLUSIONS: BMS-747158-02 exhibited high and sustained cardiac uptake that was proportional to blood flow, and it represents a new class of PET myocardial perfusion imaging agent. 相似文献